Monday, April 22, 2024

IMPORTANT COMMUNICATION: STATUS OF IFI INFECTIOUS ANTIBODY REAGENTS

 IMPORTANT COMMUNICATION: STATUS OF IFI INFECTIOUS ANTIBODY REAGENTS

Dear colleagues and collaborators, 

We inform you about an important update regarding the availability of certain tests and reagents for the Indirect Immunofluorescence (IFI) technique that we have been performing for the detection of infectious disease antibodies.

Recently, we have experienced changes in our supply chain due to circumstances beyond our control and unfortunately, our official supplier of reagents for the IFI technique has permanently ceased production of the reagents.

As a result, some of the tests we offer will be temporarily unavailable or may experience changes in availability. 

We would like to assure you that we are working diligently to minimize any inconvenience this may cause and are exploring all available options to restore the availability of these tests as soon as possible.

We would therefore like to keep you updated on the current situation arising from this event;

TEMPORARILY ERASED TESTS

TEST CODE

DESCRIPTION

OBSERVATIONS

938/ 2032/4715

RESPIRATORY SYNCYTIAL VIRUS IGG,M ANTIBODIES

Pending results will be issued on time

1009/ 1010/4699

INFLUENZA A VIRUS IGG,M ANTIBODIES

Pending results will be issued on time

2040/ 2041

INFLUENZA B VIRUS IGG,M ANTIBODIES

Pending results will be issued on time

3076

INFLUENZA (A+B) VIRUS IGM ANTIBODIES

Pending results will be issued on time

7670/ 3106/ 3229

BORDETELLA PARAPERTUSSIS IGG,M,A ANTIBODIES

Pending results will be issued on time

2064/ 2065/ 2375

BORDETELLA PERTUSSIS IGG,M,A ANTIBODIES

Pending results cannot be issued in a timely manner until test reactivation, for emergencies contact the laboratory.

TESTS UNDER FOLLOW-UP WITH POSSIBLE CHANGES IN THE SHORT TERM

TEST CODE

DESCRIPTION

OBSERVATIONS

2497/ 2498/4418

BARTONELLA HENSELAE IGG,M ANTIBODIES

Pending results will be issued on time

225/ 3536/ 1160

CANDIDA ALBICANS IGG,M,A ANTIBODIES

Pending results will be issued on time

3114/ 3115

LEPTOSPIRA INTERROGANS IGG,M ANTIBODIES

Pending results will be issued on time

4276/ 4275/ 7662

VARICELA ZOSTER IGG,M,A ANTIBODIES

Pending results will be issued on time

7686/ 7687/ 2095/ 7323/ 7324

EPSTEIN BARR VCA IGG,M,A ANTIBODIES

Pending results will be issued on time

2217/ 2218/ 4222/ 4223

IGG,M ANTIBODIES VIRUS HERPES TIPO 6

Pending results will be issued on time

2397

LEGIONELLA PNEUMOPHILA IGA ANTIBODIES

Pending results will be issued on time

2672/ 2671/ 7684/ 7685

COXSACKIE VIRUS A9 IGG,M ANTIBODIES

Pending results will be issued on time

2048/ 2047/ 7681/ 7682

COXSACKIE VIRUS B16 IGG,M ANTIBODIES

Pending results will be issued on time

2278/ 3686/ 5581/5607

GIARDIA LAMBLIA IGG,M,A ANTIBODIES

Pending results will be issued on time

4711/ 4712/ 4714/ 4713

ADENOVIRUS IGG,M ANTIBODIES

Pending results will be issued on time

7310/ 7309

PARAINFLUENZA 1 IGG,M ANTIBODIES

Pending results will be issued on time

7318/ 7319

PARAINFLUENZA 2 IGG,M ANTIBODIES

Pending results will be issued on time

7320/ 7321

PARAINFLUENZA 3 IGG,M ANTIBODIES

Pending results will be issued on time


We understand that this may raise concerns and want to assure you that we are committed to maintaining the quality and integrity of our products.

We are taking all necessary steps to mitigate any impact on your clinical practice and are available to provide the necessary support during this transition period.

Please do not hesitate to contact us for any further clarification.

Yours sincerely,



No comments:

Post a Comment